Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Stabilizing pharmaco-active Membrane proteins with Zwitterionic polymers and leveraging Surface Plasmon Resonance as an Analytical platform

Project description

Stabilising glutamate receptors for drug discovery

Glutamate constitutes one of the main excitatory chemical messengers in the brain and binds to metabotropic glutamate receptors (mGluRs), modulating synaptic plasticity, learning, and memory. mGluRs are implicated in neurological and psychiatric disorders and are therefore promising drug target candidates. However, efforts to study and target mGluRs are hampered by difficulties in stabilising their active conformations in vitro. With the support of the Marie Skłodowska-Curie Actions programme, the ZwitterMPs project aims to stabilise mGluR1 by mimicking the lipid membrane using amphiphilic zwitterionic polymers. The latter help maintain the receptor's structural and functional integrity and facilitate their investigation with valuable insights into protein-drug interactions.

Objective

Membrane proteins, particularly G-protein-coupled receptors (GPCRs), represent 25-30% of current drug targets. Among them, metabotropic glutamate receptor (mGluR), a Class C and group 1 type GPCR, is emerging as an attractive therapeutic target for various neurological and psychiatric disorders such as Alzheimer’s disease, Parkinson's disease, autism spectrum disorder, schizophrenia, and neuropathic pain.
Despite the availability of its complete structure, biophysical characterization and drug discovery efforts targeting mGluR have been hindered by the challenges in obtaining stable, active conformations of this receptor for in-vitro studies. To overcome this impediment, we will utilize amphiphilic zwitterionic polymers, for stabilizing mGluR. Carefully synthesizing copolymers can mimic the native lipid environment and maintain the receptor's structural and functional integrity. Zwitterionic polymers, with their unique molecular architecture featuring both anionic and cationic groups, structure surrounding water molecules, creating super-hydrophilic surfaces ideal for stabilizing membrane proteins with exposed hydrophobic domains.
To evaluate this stabilization strategy, we first aim to employ the label-free bio-analytical technique of surface plasmon resonance to immobilize the mGluR-polymer complex. Secondly, we will investigate binding kinetics, affinities, and allosteric modulation of mGluR1 receptor to obtain valuable insights into protein-drug interactions. We anticipate this innovative strategy will address the existing challenges in stabilizing mGluR, offering improved stability, reduced complexity, cost-effectiveness, and higher yields over conventional methods. Moreover, it will accelerate drug screening practices targeting mGluR and other challenging membrane protein targets in the long run, thereby contributing to developing novel therapeutics for neurological and psychiatric disorders.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

FYZIKALNI USTAV AV CR, VVI
Net EU contribution
€ 207 758,16
Address
NA SLOVANCE 1999/2
182 00 PRAHA 8
Czechia
Region
Česko Praha Hlavní město Praha
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (2)